Allergic conjunctivitis is a common ophthalmic disease, and clinical treatment lacks ideal drugs. It is necessary to develop new drugs with good efficacy and minimal side effects to treat allergic conjunctivitis. Evaluating the efficacy of new drugs requires establishing an animal model of allergic conjunctivitis.

Observation indicators

Check for congestion, edema, and secretions in the conjunctiva on the ocular surface, and assess vascular permeability.

Partial experimental diagram display